PROCEPT BioRobotics (PRCT) FCF Margin (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of FCF Margin data on file, last reported at 49.37% in Q1 2026.

• On a quarterly basis, FCF Margin fell 2281.0% year-over-year to 49.37% in Q1 2026; TTM through Mar 2026 was 25.16%, a 900.0% increase from a year earlier, with the FY2025 full-year figure at 18.94%, up 2541.0% from the prior year.
• FCF Margin for Q1 2026 stood at 49.37%, down from 15.94% in the prior quarter.
• Over the last five years, FCF Margin for PRCT reached as high as 11.4% in Q3 2025 and fell as low as 169.1% in Q1 2023.
• Historically, FCF Margin has averaged 66.19% across 5 years, with a median of 49.37% in 2026.
• Across the five-year window, FCF Margin slumped 3821 bps in 2023 and surged 9535 bps in 2024, its largest moves.
• Year by year, FCF Margin stood at 113.26% in 2022, then soared by 79 bps to 23.32% in 2023, then tumbled by 106 bps to 47.94% in 2024, then surged by 67 bps to 15.94% in 2025, then sank by 210 bps to 49.37% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 49.37% in Q1 2026, 15.94% in Q4 2025, and 11.4% in Q3 2025.